TATDNCRISPRプラスミド
サンタクルスバイオテクノロジー社は遺伝子サイレンシング用のCRISPR/Cas9ノックアウト及びCRISPR Double Nickaseプラスミドを含め、広範囲の遺伝子編集製品を提供しております。TATDN遺伝子サイレンサーは、TATDN CRISPR/Cas9ノックアウトプラスミドとTATDNDouble Nickaseプラスミドとして利用可能です。遺伝子活性化用のTATDNCRISPR/dCas9 Activationプラスミド及びCRISPR Lenti Activationシステムも利用できます。遺伝子サイレンサーと活性化剤はタンパク質の検出に使用された抗体と組み合わせた遺伝子研究に有用です。
TATDN CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
TATDN1 CRISPR/Cas9 KOプラスミド (h) | sc-410184 | h | Gene Knockout | GFP | 0 | ||
TATDN1 HDRプラスミド (h) | sc-410184-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
TATDN1 Double Nickaseプラスミド (h) | sc-410184-NIC | h | Gene Knockout | Puromycin | 0 | ||
TATDN1 Double Nickaseプラスミド (h2) | sc-410184-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
TATDN1 CRISPR/Cas9 KOプラスミド (m) | sc-427497 | m | Gene Knockout | GFP | 0 | ||
TATDN1 HDRプラスミド (m) | sc-427497-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
TATDN1 Double Nickaseプラスミド (m) | sc-427497-NIC | m | Gene Knockout | Puromycin | 0 | ||
TATDN1 Double Nickaseプラスミド (m2) | sc-427497-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
TATDN2 CRISPR/Cas9 KOプラスミド (h) | sc-411345 | h | Gene Knockout | GFP | 0 | ||
TATDN2 HDRプラスミド (h) | sc-411345-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
TATDN2 Double Nickaseプラスミド (h) | sc-411345-NIC | h | Gene Knockout | Puromycin | 0 | ||
TATDN2 Double Nickaseプラスミド (h2) | sc-411345-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
TATDN2 CRISPR/Cas9 KOプラスミド (m) | sc-436327 | m | Gene Knockout | GFP | 0 | ||
TATDN2 HDRプラスミド (m) | sc-436327-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
TATDN2 Double Nickaseプラスミド (m) | sc-436327-NIC | m | Gene Knockout | Puromycin | 0 | ||
TATDN2 Double Nickaseプラスミド (m2) | sc-436327-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
TATDN3 CRISPR/Cas9 KOプラスミド (h) | sc-414327 | h | Gene Knockout | GFP | 0 | ||
TATDN3 HDRプラスミド (h) | sc-414327-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
TATDN3 Double Nickaseプラスミド (h) | sc-414327-NIC | h | Gene Knockout | Puromycin | 0 | ||
TATDN3 Double Nickaseプラスミド (h2) | sc-414327-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
TATDN3 CRISPR/Cas9 KOプラスミド (m) | sc-427249 | m | Gene Knockout | GFP | 0 | ||
TATDN3 HDRプラスミド (m) | sc-427249-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
TATDN3 Double Nickaseプラスミド (m) | sc-427249-NIC | m | Gene Knockout | Puromycin | 0 | ||
TATDN3 Double Nickaseプラスミド (m2) | sc-427249-NIC-2 | m | Gene Knockout | Puromycin | 0 |
TATDN CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
TATDN1 CRISPR Activationプラスミド (h) | sc-410184-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TATDN1 CRISPR Activationプラスミド (h2) | sc-410184-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TATDN1 Lentiviral Activation Particles (h) | sc-410184-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TATDN1 Lentiviral Activation Particles (h2) | sc-410184-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TATDN1 CRISPR Activationプラスミド (m) | sc-427497-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TATDN1 CRISPR Activationプラスミド (m2) | sc-427497-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TATDN1 Lentiviral Activation Particles (m) | sc-427497-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TATDN1 Lentiviral Activation Particles (m2) | sc-427497-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TATDN2 CRISPR Activationプラスミド (h) | sc-411345-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TATDN2 CRISPR Activationプラスミド (h2) | sc-411345-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TATDN2 Lentiviral Activation Particles (h) | sc-411345-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TATDN2 Lentiviral Activation Particles (h2) | sc-411345-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TATDN2 CRISPR Activationプラスミド (m) | sc-436327-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TATDN2 CRISPR Activationプラスミド (m2) | sc-436327-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TATDN2 Lentiviral Activation Particles (m) | sc-436327-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TATDN2 Lentiviral Activation Particles (m2) | sc-436327-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TATDN3 CRISPR Activationプラスミド (h) | sc-414327-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TATDN3 CRISPR Activationプラスミド (h2) | sc-414327-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TATDN3 Lentiviral Activation Particles (h) | sc-414327-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TATDN3 Lentiviral Activation Particles (h2) | sc-414327-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TATDN3 CRISPR Activationプラスミド (m) | sc-427249-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TATDN3 CRISPR Activationプラスミド (m2) | sc-427249-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TATDN3 Lentiviral Activation Particles (m) | sc-427249-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TATDN3 Lentiviral Activation Particles (m2) | sc-427249-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |